Evaluating measurable residual disease in acute myeloid leukemia
Abstract: Mounting evidence indicates that the presence of measurable (“minimal”) residual disease (MRD), defined as posttherapy persistence of leukemic cells at levels below morphologic detection, is a strong, independent prognostic marker of increased risk of relapse and shorter survival in patien...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Elsevier
2018-06-01
|
| Collection: | Blood Advances |
| Accès en ligne: | http://www.sciencedirect.com/science/article/pii/S2473952920309976 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|